Table of Contents Author Guidelines Submit a Manuscript

Aims and Scope

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.

Subject areas include (but are by no means limited to):

  • Acute coronary syndrome
  • Arrhythmias
  • Atherosclerosis
  • Basic cardiac electrophysiology
  • Cardiac catheterization
  • Cardiac remodeling
  • Coagulation and thrombosis
  • Diabetic cardiovascular disease
  • Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
  • Hyperlipidemia
  • Hypertension
  • Ischemic heart disease
  • Vascular biology
  • Ventricular assist devices
  • Molecular cardio-biology
  • Myocardial regeneration
  • Lipoprotein metabolism
  • Radial artery access
  • Percutaneous coronary intervention
  • Transcatheter aortic and mitral valve replacement